90 related articles for article (PubMed ID: 11522238)
1. In vitro production of dendritic cells from human blood monocytes for therapeutic use.
Garderet L; Cao H; Salamero J; Vergé V; Tisserand E; Scholl S; Gorin NC; Lopez M
J Hematother Stem Cell Res; 2001 Aug; 10(4):553-67. PubMed ID: 11522238
[TBL] [Abstract][Full Text] [Related]
2. In vitro generation of dendritic cells from human blood monocytes in experimental conditions compatible for in vivo cell therapy.
Cao H; Vergé V; Baron C; Martinache C; Leon A; Scholl S; Gorin NC; Salamero J; Assari S; Bernard J; Lopez M
J Hematother Stem Cell Res; 2000 Apr; 9(2):183-94. PubMed ID: 10813531
[TBL] [Abstract][Full Text] [Related]
3. Cryopreservation of Dendritic Cells Grown in Vitro from Monocytes for Their Future Clinical Use.
Cao H; Verg V; Martinache C; Leon A; Gorin NC; Bernard J; Lopez M
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2000 Dec; 8(4):245-250. PubMed ID: 12578659
[TBL] [Abstract][Full Text] [Related]
4. Differential effects of autologous serum on CD34(+) or monocyte-derived dendritic cells.
Loudovaris M; Hansen M; Suen Y; Lee SM; Casing P; Bender JG
J Hematother Stem Cell Res; 2001 Aug; 10(4):569-78. PubMed ID: 11522239
[TBL] [Abstract][Full Text] [Related]
5. Replicative response, immunophenotype, and functional activity of monocyte-derived versus CD34(+)-derived dendritic cells following exposure to various expansion and maturational stimuli.
Chen B; Stiff P; Sloan G; Kash J; Manjunath R; Pathasarathy M; Oldenburg D; Foreman KE; Nickoloff BJ
Clin Immunol; 2001 Feb; 98(2):280-92. PubMed ID: 11161986
[TBL] [Abstract][Full Text] [Related]
6. Effective clinical-scale production of dendritic cell vaccines by monocyte elutriation directly in medium, subsequent culture in bags and final antigen loading using peptides or RNA transfection.
Erdmann M; Dörrie J; Schaft N; Strasser E; Hendelmeier M; Kämpgen E; Schuler G; Schuler-Thurner B
J Immunother; 2007 Sep; 30(6):663-74. PubMed ID: 17667530
[TBL] [Abstract][Full Text] [Related]
7. Molecular and functional characteristics of dendritic cells generated from highly purified CD14+ peripheral blood monocytes.
Pickl WF; Majdic O; Kohl P; Stöckl J; Riedl E; Scheinecker C; Bello-Fernandez C; Knapp W
J Immunol; 1996 Nov; 157(9):3850-9. PubMed ID: 8892615
[TBL] [Abstract][Full Text] [Related]
8. Development of a closed-system process for clinical-scale generation of DCs: evaluation of two monocyte-enrichment methods and two culture containers.
Wong EC; Lee SM; Hines K; Lee J; Carter CS; Kopp W; Bender J; Read EJ
Cytotherapy; 2002; 4(1):65-76. PubMed ID: 11953043
[TBL] [Abstract][Full Text] [Related]
9. Experimental production of clinical-grade dendritic cell vaccine for acute myeloid leukemia.
Tan YF; Sim GC; Habsah A; Leong CF; Cheong SK
Malays J Pathol; 2008 Dec; 30(2):73-9. PubMed ID: 19291915
[TBL] [Abstract][Full Text] [Related]
10. Large-scale immunomagnetic selection of CD14+ monocytes to generate dendritic cells for cancer immunotherapy: a phase I study.
Babatz J; Röllig C; Oelschlägel U; Zhao S; Ehninger G; Schmitz M; Bornhäuser M
J Hematother Stem Cell Res; 2003 Oct; 12(5):515-23. PubMed ID: 14594508
[TBL] [Abstract][Full Text] [Related]
11. Closed system generation of dendritic cells from a single blood volume for clinical application in immunotherapy.
Elias M; van Zanten J; Hospers GA; Setroikromo A; de Jong MA; de Leij LF; Mulder NH
J Clin Apher; 2005 Dec; 20(4):197-207. PubMed ID: 15892082
[TBL] [Abstract][Full Text] [Related]
12. A method for the production of cryopreserved aliquots of antigen-preloaded, mature dendritic cells ready for clinical use.
Feuerstein B; Berger TG; Maczek C; Röder C; Schreiner D; Hirsch U; Haendle I; Leisgang W; Glaser A; Kuss O; Diepgen TL; Schuler G; Schuler-Thurner B
J Immunol Methods; 2000 Nov; 245(1-2):15-29. PubMed ID: 11042280
[TBL] [Abstract][Full Text] [Related]
13. Mature dendritic cells generated from patient-derived peripheral blood monocytes in one-step culture using streptococcal preparation OK-432 exert an enhanced antigen-presenting capacity.
Naito K; Ueda Y; Itoh T; Fuji N; Shimizu K; Yano Y; Yamamoto Y; Imura K; Kohara J; Iwamoto A; Shiozaki A; Tamai H; Shimizu T; Mazda O; Yamagishi H
Int J Oncol; 2006 Jun; 28(6):1481-9. PubMed ID: 16685449
[TBL] [Abstract][Full Text] [Related]
14. Monocyte-derived dendritic cells: development of a cellular processor for clinical applications.
Goxe B; Latour N; Bartholeyns J; Romet-Lemonne JL; Chokri M
Res Immunol; 1998; 149(7-8):643-6. PubMed ID: 9851516
[TBL] [Abstract][Full Text] [Related]
15. Comparison of monocyte enrichment by immuno-magnetic depletion or adherence for the clinical-scale generation of DC.
Suen Y; Lee SM; Aono F; Hou S; Loudovaris M; Ofstein G; Bender JG
Cytotherapy; 2001; 3(5):365-75. PubMed ID: 11953016
[TBL] [Abstract][Full Text] [Related]
16. Development and validation of a fully GMP-compliant production process of autologous, tumor-lysate-pulsed dendritic cells.
Eyrich M; Schreiber SC; Rachor J; Krauss J; Pauwels F; Hain J; Wölfl M; Lutz MB; de Vleeschouwer S; Schlegel PG; Van Gool SW
Cytotherapy; 2014 Jul; 16(7):946-64. PubMed ID: 24831836
[TBL] [Abstract][Full Text] [Related]
17. Generation of dendritic cells from human bone marrow mononuclear cells: advantages for clinical application in comparison to peripheral blood monocyte derived cells.
Bai L; Feuerer M; Beckhove P; Umansky V; Schirrmacher V
Int J Oncol; 2002 Feb; 20(2):247-53. PubMed ID: 11788884
[TBL] [Abstract][Full Text] [Related]
18. Differentiation of human dendritic cells from monocytes in vitro.
Chapuis F; Rosenzwajg M; Yagello M; Ekman M; Biberfeld P; Gluckman JC
Eur J Immunol; 1997 Feb; 27(2):431-41. PubMed ID: 9045914
[TBL] [Abstract][Full Text] [Related]
19. Comparison of phenotypic and functional dendritic cells derived from human umbilical cord blood and peripheral blood mononuclear cells.
Joshi SS; Vu UE; Lovgren TR; Lorkovic M; Patel W; Todd GL; Kuszynski C; Joshi BJ; Dave HP
J Hematother Stem Cell Res; 2002 Apr; 11(2):337-47. PubMed ID: 11983105
[TBL] [Abstract][Full Text] [Related]
20. Cryopreservation of mature monocyte-derived human dendritic cells for vaccination: influence on phenotype and functional properties.
Westermann J; Körner IJ; Kopp J; Kurz S; Zenke M; Dörken B; Pezzutto A
Cancer Immunol Immunother; 2003 Mar; 52(3):194-8. PubMed ID: 12649749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
